Clinical trials
Terminated Burns trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Texas Medical Branch, Galveston | 10 |
| Shriners Hospitals for Children | 5 |
| Massachusetts General Hospital | 3 |
| United States Army Institute of Surgical Research | 3 |
| Aubrey Inc. | 2 |
| Noveome Biotherapeutics, formerly Stemnion | 2 |
| Texas Tech University Health Sciences Center | 2 |
| University of Texas Southwestern Medical Center | 2 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Avita Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burns | 61 |
| Wounds and Injuries | 5 |
| Pain | 4 |
| Anxiety Disorders | 2 |
| Cicatrix | 2 |
| Insulin Resistance | 2 |
| Ulcer | 2 |
| Arrhythmias, Cardiac | 1 |
| Cachexia | 1 |
| Chronic Pain | 1 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.